Skip to main content
Signal8

KEEGAN JOSEPH D

SEC insider (Form 3/4/5 filer). CIK 0001260556. Director at INTERPACE BIOSCIENCES, INC. (IDXG) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 20, 2026. Located in PARSIPPANY, NJ.

Companies KEEGAN JOSEPH D has filed insider reports for

  • INTERPACE BIOSCIENCES, INC. (IDXG): Director
  • BIO-TECHNE Corp (TECH): Director
KEEGAN JOSEPH D profile photo

KEEGAN JOSEPH D

CIK: 0001260556

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

INTERPACE BIOSCIENCES, INC. logo
IDXG

INTERPACE BIOSCIENCES, INC.

Director
BIO-TECHNE Corp logo
TECH

BIO-TECHNE Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • INTERPACE BIOSCIENCES, INC. logo
    IDXG

    INTERPACE BIOSCIENCES, INC.

    Aug 20, 2026
    Award

    Restricted Stock Units

    Direct
    69.3K shares-
  • BIO-TECHNE Corp logo
    TECH

    BIO-TECHNE Corp

    Oct 30, 2025
    Award
    Direct
    1.6K shares-
  • BIO-TECHNE Corp logo
    TECH

    BIO-TECHNE Corp

    Oct 24, 2024
    Award
    Direct
    1.5K shares-

1-3 of 3